NIH-funded research R01 grant

Investigating how to predict epilepsy in newborns with seizures

Official title: NS-PEACE Neonatal Seizures -Predicting Epilepsy and Assessing Comparative Effectiveness

Funded at Weill Medical Coll of Cornell Univ · NIH-11074027 · Data updated 2026-11-12

This study is looking at the best medications to help newborns who have seizures, which can sometimes lead to bigger health issues later on, and it's for families with babies who might be experiencing these seizures.

More Epilepsy research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionWeill Medical Coll of Cornell Univ
NIH-funded
Lab location1 site (New York, United States)
Project startMay 1, 2023
Project endApril 30, 2028
Funding year2025
Award (this year)$677,582
NIH project number5R01NS130113-03
Project IDNIH-11074027 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are newborns aged 0-28 days who have experienced acute symptomatic seizures.

Less likely to help

Patients who do not have neonatal seizures or are older than 28 days may not benefit from this research.

What this research studies

This research focuses on understanding neonatal seizures, which occur in about 1 in 1000 live births and can lead to serious conditions like epilepsy and cerebral palsy. The study aims to determine the most effective medications for treating these seizures and to explore how different treatments may influence the risk of developing further seizure disorders as the child grows. By analyzing data from 780 neonates across 18 medical centers, the researchers will compare the effectiveness of commonly used anti-seizure medications. This research is crucial for improving treatment strategies and outcomes for affected infants.

Why it matters

Potential benefit: If successful, this research could lead to better treatment options that reduce the risk of developing epilepsy in newborns who experience seizures.

How similar studies have gone: Previous research has shown promising results in the treatment of neonatal seizures, but this specific approach to comparing medication effectiveness is relatively novel.

Where this research is happening

  • Weill Medical Coll of Cornell Univ
    New York, United States
    Active

Researchers

  • Principal investigator: Grinspan, Zachary Michael — Weill Medical Coll of Cornell Univ
  • Study coordinator: Grinspan, Zachary Michael

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.